1月7日，联化科技涨5.01%，截至发稿，报14.66元/股，成交2.13亿元，换手率1.66%，总市值131.92亿 元。联化科技股价已经连续10天上涨，区间累计涨幅0%。 资料显示，联化科技股份有限公司位于浙江省台州市黄岩区劳动北路总商会大厦17楼，成立日期1998年 9月14日，上市日期2008年6月19日，公司主营业务涉及主营工业业务分为农药、医药和功能化学品三大 板块。农药板块主要从事农药原料药及中间体的生产、销售以及为国际农药企业提供定制生产、研发及 技术服务;医药板块主要从事原料药、中间体的生产、销售以及为国际制药企业提供定制生产、研发及 技术服务;功能化学品板块主要从事精细化学品、功能化学品的生产、销售以及定制生产、研发及技术 服务。主营业务收入构成为：植保54.03%，医药32.32%，功能化学品8.42%，设备与工程服务4.88%， 其他(补充)0.36%。 从基金十大重仓股角度 数据显示，万家基金旗下1只基金重仓联化科技。万家中证2000指数增强A（019920）三季度持有股数 2.08万股，占基金净值比例为0.49%，位居第一大重仓股。根据测算，今日浮盈赚取约1.46万元。连续 10天 ...

Group 1 - The core viewpoint of the news highlights the trading performance and financial metrics of Taihe Co., Ltd. on December 18, including a slight decline in stock price and details on margin trading activities [1] - On December 18, Taihe Co., Ltd. experienced a stock price drop of 0.95%, with a trading volume of 71.56 million yuan. The net margin buying amounted to 465,100 yuan, with a total margin balance of 63.50 million yuan [1] - The company’s financing balance is 63.26 million yuan, representing 5.90% of its market capitalization, while the short selling activities included 4,200 shares sold, totaling 117,700 yuan [1] Group 2 - As of December 10, the number of shareholders for Taihe Co., Ltd. reached 11,000, an increase of 0.76%, while the average circulating shares per person decreased by 0.76% to 3,488 shares [2] - For the period from January to September 2025, Taihe Co., Ltd. reported a revenue of 3.89 billion yuan, reflecting a year-on-year growth of 28.69%, and a net profit attributable to shareholders of 367 million yuan, marking a significant increase of 120.56% [2] - The company has distributed a total of 270 million yuan in dividends since its A-share listing, indicating a commitment to returning value to shareholders [3]

每经头条（nbdtoutiao）——"太空快递"来了？全国首个民营飞船成功"上天"！背后公司创始人：正积 极开发"中型货运飞船"低成本产品 （记者 王瀚黎） 截至发稿，泰禾股份市值为127亿元。 每经AI快讯，泰禾股份（SZ 301665，收盘价：28.29元）12月17日晚间发布公告称，公司第四届第五次 董事会会议于2025年12月16日在公司会议室以现场和通讯相结合的方式召开。会议审议了《关于提请召 开公司2026年第一次临时股东会的议案》等文件。 2024年1至12月份，泰禾股份的营业收入构成为：农药占比85.02%，功能化学品占比11.2%，其他占比 3.78%。 ...

Core Viewpoint - Lianhua Technology's stock has experienced significant fluctuations, with a year-to-date increase of 111.29% but a recent decline of 22.67% over the past five trading days [1] Group 1: Stock Performance - As of November 24, Lianhua Technology's stock price is 11.60 CNY per share, with a market capitalization of 10.439 billion CNY [1] - The stock has seen a trading volume of 2.68 billion CNY and a turnover rate of 2.53% [1] - The company has appeared on the "Dragon and Tiger List" 10 times this year, with the latest appearance on November 14, where it recorded a net purchase of 124 million CNY [1] Group 2: Business Overview - Lianhua Technology, established on September 14, 1998, and listed on June 19, 2008, operates in three main sectors: pesticides, pharmaceuticals, and functional chemicals [2] - The revenue composition is as follows: pesticides 54.03%, pharmaceuticals 32.32%, functional chemicals 8.42%, equipment and engineering services 4.88%, and others 0.36% [2] - The company is categorized under the basic chemicals industry, specifically in agricultural chemical products [2] Group 3: Financial Performance - For the period from January to September 2025, Lianhua Technology achieved a revenue of 4.718 billion CNY, representing a year-on-year growth of 8.25% [2] - The net profit attributable to shareholders for the same period was 316 million CNY, showing a remarkable increase of 871.65% [2] - The company has distributed a total of 960 million CNY in dividends since its A-share listing, with 129 million CNY distributed in the last three years [3]

Group 1 - The core point of the article is that Taihe Co., Ltd. announced the convening of its fourth board meeting on November 20, 2025, to discuss the proposal for the third extraordinary shareholders' meeting in 2025 [1] - For the year 2024, the revenue composition of Taihe Co., Ltd. is as follows: pesticides account for 85.02%, functional chemicals account for 11.2%, and others account for 3.78% [1]

Group 1 - The core viewpoint of the article is that Taihe Co., Ltd. (SZ 301665) has announced its participation in a research meeting with Invesco Great Wall Fund, where company executives addressed investor inquiries [1] - For the fiscal year 2024, Taihe Co., Ltd.'s revenue composition is as follows: pesticides account for 85.02%, functional chemicals for 11.2%, and others for 3.78% [1] - As of the report, Taihe Co., Ltd. has a market capitalization of 14 billion yuan [1]

资料显示，南通泰禾化工股份有限公司位于上海市长宁区临虹路365号北5座，成立日期2004年4月29 日，上市日期2025年4月11日，公司主营业务涉及农药产品以及功能化学品的研发、生产和销售。主营 业务收入构成为：除草剂43.14%，杀菌剂37.30%，功能化学品9.98%，其他9.57%。 截至11月10日，泰禾股份股东户数1.28万，较上期增加3.62%；人均流通股2989股，较上期减少3.49%。 2025年1月-9月，泰禾股份实现营业收入38.90亿元；归母净利润3.67亿元，同比增长120.56%。 11月17日，泰禾股份涨1.34%，成交额2.12亿元。两融数据显示，当日泰禾股份获融资买入额1835.27万 元，融资偿还2650.61万元，融资净买入-815.34万元。截至11月17日，泰禾股份融资融券余额合计 8504.12万元。 融资方面，泰禾股份当日融资买入1835.27万元。当前融资余额8504.12万元，占流通市值的6.99%。 融券方面，泰禾股份11月17日融券偿还0.00股，融券卖出0.00股，按当日收盘价计算，卖出金额0.00 元；融券余量0.00股，融券余额0.00元。 分红方面 ...

Core Points - On November 12, Taihe Co., Ltd. experienced a decline of 1.65% in stock price, with a trading volume of 91.42 million yuan [1] - The financing data for Taihe on the same day showed a financing purchase amount of 8.13 million yuan and a financing repayment of 8.92 million yuan, resulting in a net financing outflow of 0.79 million yuan [1] - As of November 12, the total margin balance for Taihe was 85.12 million yuan, accounting for 7.20% of its market capitalization [1] Financing and Margin Data - The financing purchase on November 12 was 8.13 million yuan, while the current financing balance stands at 85.12 million yuan [1] - No shares were sold or repaid in the securities lending segment on November 12, with a total of 0 shares and 0 yuan in margin balance [1] Company Overview - Taihe Co., Ltd. is located in Changning District, Shanghai, and was established on April 29, 2004, with its listing date set for April 11, 2025 [1] - The company specializes in the research, production, and sales of pesticide products and functional chemicals, with revenue composition as follows: herbicides 43.14%, fungicides 37.30%, functional chemicals 9.98%, and others 9.57% [1] Financial Performance - For the period from January to September 2025, Taihe reported a revenue of 3.89 billion yuan and a net profit attributable to shareholders of 367 million yuan, reflecting a year-on-year growth of 120.56% [1] Shareholder Information - As of November 10, the number of shareholders for Taihe was 12,800, an increase of 3.62% from the previous period, with an average of 2,989 circulating shares per person, a decrease of 3.49% [1] - Since its A-share listing, Taihe has distributed a total of 270 million yuan in dividends [2] - As of September 30, 2025, Hong Kong Central Clearing Limited was the sixth largest circulating shareholder, holding 230,200 shares, a decrease of 171,700 shares from the previous period [2]

Core Viewpoint - Lianhua Technology's stock price has seen significant growth this year, with a year-to-date increase of 114.21%, despite a recent decline in trading activity [1] Group 1: Stock Performance - As of November 5, Lianhua Technology's stock price was 11.76 yuan per share, with a market capitalization of 10.717 billion yuan [1] - The stock experienced a net outflow of 29.31 million yuan in principal funds, with large orders showing a buy of 43.25 million yuan and a sell of 61.40 million yuan [1] - The stock has risen by 3.70% in the last five trading days, 7.30% in the last 20 days, and 9.40% in the last 60 days [1] Group 2: Company Overview - Lianhua Technology, established on September 14, 1998, and listed on June 19, 2008, operates in three main sectors: pesticides, pharmaceuticals, and functional chemicals [2] - The revenue composition is as follows: pesticides 54.03%, pharmaceuticals 32.32%, functional chemicals 8.42%, equipment and engineering services 4.88%, and others 0.36% [2] - The company is classified under the basic chemicals industry, specifically in pesticide products [2] Group 3: Financial Performance - For the period from January to September 2025, Lianhua Technology reported a revenue of 4.718 billion yuan, reflecting a year-on-year growth of 8.25% [2] - The net profit attributable to shareholders was 316 million yuan, showing a remarkable year-on-year increase of 871.65% [2] - The company has distributed a total of 960 million yuan in dividends since its A-share listing, with 129 million yuan distributed in the last three years [3]

Group 1 - The core point of the article highlights the recent performance of Lianhua Technology, which saw a 5.15% increase in stock price, reaching 12.26 yuan per share, with a trading volume of 549 million yuan and a turnover rate of 5.07%, resulting in a total market capitalization of 11.173 billion yuan [1] - Lianhua Technology, established on September 14, 1998, and listed on June 19, 2008, operates in three main business segments: pesticides, pharmaceuticals, and functional chemicals. The revenue composition is as follows: plant protection 54.03%, pharmaceuticals 32.32%, functional chemicals 8.42%, equipment and engineering services 4.88%, and others 0.36% [1] Group 2 - From the perspective of fund holdings, only one fund under Wanjia Fund has Lianhua Technology as a major holding. The Wanjia CSI 2000 Index Enhanced A fund (019920) held 20,800 shares in the third quarter, accounting for 0.49% of the fund's net value, making it the largest holding. The estimated floating profit for today is approximately 12,500 yuan [2] - The Wanjia CSI 2000 Index Enhanced A fund is managed by Qiao Liang and Zhang Yongqiang. As of the report, Qiao Liang has a tenure of 6 years and 70 days, with a total asset scale of 5.886 billion yuan and a best fund return of 123.25% during his tenure. Zhang Yongqiang has a tenure of 2 years and 299 days, with a total asset scale of 1.806 billion yuan and a best fund return of 41.25% during his tenure [3]